McMullan P - Search Results

1

Prevalence of Chiari malformation type 1 is increased in pseudohypoparathyroidism type 1A and associated with aberrant bone development.

Krishnan N, McMullan P, Yang Q, Buscarello AN, Germain-Lee EL. Krishnan N, et al. Among authors: mcmullan p. PLoS One. 2023 Jan 20;18(1):e0280463. doi: 10.1371/journal.pone.0280463. eCollection 2023. PLoS One. 2023. PMID: 36662765 Free PMC article.

2

Parental Origin of Gsα Inactivation Differentially Affects Bone Remodeling in a Mouse Model of Albright Hereditary Osteodystrophy.

McMullan P, Maye P, Yang Q, Rowe DW, Germain-Lee EL. McMullan P, et al. JBMR Plus. 2021 Nov 16;6(1):e10570. doi: 10.1002/jbm4.10570. eCollection 2022 Jan. JBMR Plus. 2021. PMID: 35079678 Free PMC article.

3

Aberrant Bone Regulation in Albright Hereditary Osteodystrophy dueto Gnas Inactivation: Mechanisms and Translational Implications.

McMullan P, Germain-Lee EL. McMullan P, et al. Curr Osteoporos Rep. 2022 Feb;20(1):78-89. doi: 10.1007/s11914-022-00719-w. Epub 2022 Feb 28. Curr Osteoporos Rep. 2022. PMID: 35226254 Review.

4

Cutaneous CD30 positive anaplastic large cell lymphoma mimicking breast carcinoma en cuirasse.

McMullan P, Brown R, Bibb L, Ferenczi K. McMullan P, et al. JAAD Case Rep. 2023 Aug 19;40:37-40. doi: 10.1016/j.jdcr.2023.07.023. eCollection 2023 Oct. JAAD Case Rep. 2023. PMID: 37701888 Free PMC article. No abstract available.

5

Painful, Nonhealing, Violaceus Plaque on the Right Breast.

McMullan P, Bibb LA, Ferenczi K. McMullan P, et al. Cutis. 2023 Jul;112(1):11-27. doi: 10.12788/cutis.0805. Cutis. 2023. PMID: 37611313 No abstract available.

6

Atypical Wells syndrome successfully treated with dupilumab.

McMullan P, Torre K, Santiago S, Weston G, Lu J. McMullan P, et al. Skin Health Dis. 2023 Feb 24;3(3):e206. doi: 10.1002/ski2.206. eCollection 2023 Jun. Skin Health Dis. 2023. PMID: 37275406 Free PMC article.

7

Superficial erosions in a pediatric patient.

McMullan P, Gochnauer H, Brown-Joel Z, O'Donnell P, Belazarian L. McMullan P, et al. Pediatr Dermatol. 2024 May 7. doi: 10.1111/pde.15636. Online ahead of print. Pediatr Dermatol. 2024. PMID: 38712655 No abstract available.

8

Treatment of recalcitrant disseminated ulcerative necrobiosis lipoidica with ustekinumab.

McMullan P, Khan A, Adalsteinsson JA, Waldman R, Stewart C, Sloan B, Rothe M. McMullan P, et al. JAAD Case Rep. 2023 Jul 7;41:52-56. doi: 10.1016/j.jdcr.2023.06.040. eCollection 2023 Nov. JAAD Case Rep. 2023. PMID: 37842159 Free PMC article. No abstract available.

9

Response to Smith and Shaw "Response to "Safety of dermatologic medications in pregnancy and lactation: An update - Part 1: Pregnancy & Part 2: Lactation"".

McMullan P, Yaghi M, Truong TM, Rothe M, Murase J, Grant-Kels JM. McMullan P, et al. J Am Acad Dermatol. 2024 Apr 12:S0190-9622(24)00628-5. doi: 10.1016/j.jaad.2024.04.017. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 38614252 No abstract available.

10

Safety of dermatologic medications in pregnancy and lactation: An Update - Part II: Lactation.

Yaghi M, McMullan P, Truong TM, Rothe M, Murase J, Grant-Kels JM. Yaghi M, et al. Among authors: mcmullan p. J Am Acad Dermatol. 2024 Jan 25:S0190-9622(24)00110-5. doi: 10.1016/j.jaad.2023.10.071. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 38280680 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

65 results

Search Page